ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,846.00
      0.00%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      85.59
      -1.06%
      Bitcoin
      57,102.72
      2.25%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU
      6. Inventiva (IVA)

      7. Inventiva (IVA) News

      IVA

      Inventiva (IVA)

      Inventiva
      		Date:
      Sort by:
       Showing the most relevant articles for your search:EU:IVA
      DateTimeSourceHeadlineSymbolCompany
      01/04/20234:00PMGlobeNewswire Inc.Inventiva annonce des changements au développement clinique de lanifibranor notamment la préparation d’une nouvelle étude de Phase III chez les patients atteints de NASH avec une cirrhose compenséeEU:IVAInventiva
      01/04/20234:00PMGlobeNewswire Inc.Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosisEU:IVAInventiva
      01/04/20234:00PMGlobeNewswire Inc.Inventiva announces changes to the clinical development of lanifibranor, including plans for a new Phase III trial in patients with NASH and compensated cirrhosisEU:IVAInventiva
      01/03/20232:35AMGlobeNewswire Inc.Information relative au nombre total de droits de vote et d’actions composant le capital social au 19 décembre 2022EU:IVAInventiva
      01/03/20232:35AMGlobeNewswire Inc.Statement of total voting rights and shares forming the company’s share capital as of December 19, 2022EU:IVAInventiva
      01/03/20232:30AMGlobeNewswire Inc.Combined General Meeting of January 25, 2023 - Availability of the preparatory documentsEU:IVAInventiva
      01/03/20232:30AMGlobeNewswire Inc. Assemblée Générale Mixte du 25 janvier 2023 - Modalités de mise à disposition des documents préparatoiresEU:IVAInventiva
      12/12/20222:30AMGlobeNewswire Inc.Inventiva draws down €25 million tranche under Finance Contract with the European Investment BankEU:IVAInventiva
      12/12/20222:30AMGlobeNewswire Inc.Inventiva draws down €25 million tranche under Finance Contract with the European Investment BankEU:IVAInventiva
      12/12/20222:30AMGlobeNewswire Inc.Inventiva annonce le tirage de la première tranche de 25 millions d'euros dans le cadre de son Contrat de Financement avec la Banque Européenne d'InvestissementEU:IVAInventiva
      11/28/20224:00PMGlobeNewswire Inc.Inventiva secures a new patent expanding the IP protection of its lead product candidate lanifibranor in the USEU:IVAInventiva
      11/28/20224:00PMGlobeNewswire Inc.Inventiva obtient un nouveau brevet élargissant la protection de la propriété intellectuelle de son produit candidat phare lanifibranor aux États-UnisEU:IVAInventiva
      11/28/20224:00PMGlobeNewswire Inc.Inventiva secures a new patent expanding the IP protection of its lead product candidate lanifibranor in the USEU:IVAInventiva
      11/21/20224:00PMGlobeNewswire Inc.Inventiva announces a new Director of the Board of DirectorsEU:IVAInventiva
      11/21/20224:00PMGlobeNewswire Inc.Inventiva announces a new Director of the Board of DirectorsEU:IVAInventiva
      11/21/20224:00PMGlobeNewswire Inc.Inventiva annonce l’arrivée d’un nouveau directeur au sein de son Conseil d'AdministrationEU:IVAInventiva
      11/10/20224:00PMGlobeNewswire Inc.Inventiva reports 2022 Third Quarter Financial Information¹EU:IVAInventiva
      11/10/20224:00PMGlobeNewswire Inc.Inventiva publie ses informations financières du 3ème trimestre 2022¹EU:IVAInventiva
      11/10/20224:00PMGlobeNewswire Inc.Inventiva reports 2022 Third Quarter Financial Information¹EU:IVAInventiva
      10/31/20223:00AMGlobeNewswire Inc.Inventiva fait le point sur le développement de cedirogant par AbbVieEU:IVAInventiva
      10/31/20223:00AMGlobeNewswire Inc.Inventiva provides an update on the development of cedirogant by AbbVieEU:IVAInventiva
      10/31/20223:00AMGlobeNewswire Inc.Inventiva provides an update on the development of cedirogant by AbbVieEU:IVAInventiva
      10/21/20224:00PMGlobeNewswire Inc.Inventiva announces a scientific presentation at the AASLD The Liver Meeting® 2022EU:IVAInventiva
      10/21/20224:00PMGlobeNewswire Inc.Inventiva announces a scientific presentation at the AASLD The Liver Meeting® 2022EU:IVAInventiva
      10/21/20224:00PMGlobeNewswire Inc.Inventiva annonce la présentation d’un abstract scientifique lors du The Liver Meeting™ 2022 organisé par l’AASLDEU:IVAInventiva
      09/22/202210:38AMDow Jones NewsInventiva ADRs Rise 22% After Licensing Deal With Chia Tai-Tianqing PharmaEU:IVAInventiva
      09/22/20222:30AMGlobeNewswire Inc.Inventiva publie ses résultats financiers du 1er semestre 2022 et fait un point sur ses activitésEU:IVAInventiva
      09/22/20222:30AMGlobeNewswire Inc.Inventiva reports its 2022 first-half financial results and provides a corporate updateEU:IVAInventiva
      09/22/20222:30AMGlobeNewswire Inc.Inventiva reports its 2022 first-half financial results and provides a corporate updateEU:IVAInventiva
      09/21/20224:40PMGlobeNewswire Inc.Inventiva et Sino Biopharm signent un accord de licence et de collaboration pour développer et commercialiser lanifibranor en ChineEU:IVAInventiva
       Showing the most relevant articles for your search:EU:IVA